APA (7th ed.) Citation

JS, D., M, C., F, T., PR, P., M, G., G, M., . . . A, N. (2022). Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2. EBioMedicine, 82, 104148. https://doi.org/10.1016/j.ebiom.2022.104148

Chicago Style (17th ed.) Citation

JS, Driouich, et al. "Pre-clinical Evaluation of Antiviral Activity of Nitazoxanide Against SARS-CoV-2." EBioMedicine 82 (2022): 104148. https://doi.org/10.1016/j.ebiom.2022.104148.

MLA (9th ed.) Citation

JS, Driouich, et al. "Pre-clinical Evaluation of Antiviral Activity of Nitazoxanide Against SARS-CoV-2." EBioMedicine, vol. 82, 2022, p. 104148, https://doi.org/10.1016/j.ebiom.2022.104148.